Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2016-05, Vol.34 (15), p.e141-e144
Hauptverfasser:	Falchook, Gerald S, Ordóñez, Nelson G, Bastida, Christel C, Stephens, Philip J, Miller, Vincent A, Gaido, Lindsay, Jackson, Tiffiny, Karp, Daniel D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Cytoskeletal Proteins - antagonists & inhibitors Cytoskeletal Proteins - metabolism Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - metabolism Lung Neoplasms - pathology Neoplasm Metastasis Oncogene Proteins, Fusion - antagonists & inhibitors Oncogene Proteins, Fusion - metabolism Piperidines - therapeutic use Proto-Oncogene Proteins c-ret - antagonists & inhibitors Proto-Oncogene Proteins c-ret - metabolism Quinazolines - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!